On Nov. 19, 2020, the Department of Defense (DOD), in coordination with the Department of Health and Human Services (HHS), awarded a contract action with a not-to-exceed value of $11.6 million to Puritan Medical Products Company, LLC, to expand industrial production capacity of Cue’s sample wand nasal swabs.
The global increase in COVID-19 cases continues to impact diagnostic test manufacturers and the supply chains that support specimen collection and testing performance. This award’s modification to the industrial base expansion effort will allow Puritan Medical to expedite implementation of facility upgrades and enable an early, interim production capability of 3 million of Cue’s sample wand nasal swabs per month by March 2021, to support domestic COVID-19 testing with Cue Health’s point of care testing.
The DOD’s Defense Assisted Acquisition Cell led this effort, in coordination with HHS. The Health Care Enhancement Act funded this effort, to support domestic industrial base expansion for critical medical resources.